Mason Morfit ValueAct Holdings
Mason Morfit is chief executive officer of ValueAct Capital, a major constructive-activist investment firm. ValueAct typically takes significant stakes in companies and works with boards on strategy, capital allocation, and operational improvement. Morfit’s campaigns and holdings are closely watched in both activist and fundamental investing communities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seagate
STX
|
+$187M |
| 2 |
KKR & Co
KKR
|
+$91.5M |
| 3 |
AFI
Armstrong Flooring, Inc.
AFI
|
+$170K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$480M |
| 2 |
CBRE Group
CBRE
|
+$261M |
| 3 |
Willis Towers Watson
WTW
|
+$209M |
| 4 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$74.8M |
| 5 |
NETSCOUT
NTCT
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 30.02% |
| 2 | Energy | 15.29% |
| 3 | Technology | 15.18% |
| 4 | Communication Services | 13.28% |
| 5 | Real Estate | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHI
1
DELISTED
Baker Hughes
BHI
| $1.71B | 15.29% |
31,407,820
| – | – |
|
2
Bread Financial
BFH
$4.07B
| $1.51B | 13.48% |
7,364,382
| – | – |
|
|
TFCF
3
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $1.49B | 13.28% |
53,326,334
| – | – |
|
|
4
CBRE Group
CBRE
$44B
| $1.25B | 11.18% |
34,378,480
-7,494,770
| -18% | -$261M |
|
|
5
Microsoft
MSFT
$3.59T
| $1.1B | 9.86% |
16,012,799
-6,999,290
| -30% | -$480M |
|
|
6
Willis Towers Watson
WTW
$31.8B
| $961M | 8.59% |
6,609,358
-1,498,657
| -18% | -$209M |
|
7
Morgan Stanley
MS
$336B
| $797M | 7.12% |
17,884,620
| – | – |
|
|
8
Seagate
STX
$193B
| $535M | 4.78% |
13,815,765
+4,276,275
| +45% | +$187M |
|
9
Trinity Industries
TRN
$2.37B
| $437M | 3.9% |
21,644,238
| – | – |
|
|
BIVV
10
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $431M | 3.85% |
7,163,892
-1,313,000
| -15% | -$74.8M |
|
11
Armstrong World Industries
AWI
$7.55B
| $423M | 3.78% |
9,200,000
| – | – |
|
12
Bausch Health
BHC
$2.41B
| $311M | 2.78% |
17,997,224
| – | – |
|
|
13
KKR & Co
KKR
$97.4B
| $93M | 0.83% |
+5,000,000
| New | +$91.5M |
|
|
AFI
14
DELISTED
Armstrong Flooring, Inc.
AFI
| $82.8M | 0.74% |
4,609,071
+9,071
| +0.2% | +$170K |
|
|
15
NETSCOUT
NTCT
$2.8B
| $60.2M | 0.54% |
1,750,943
-549,057
| -24% | -$19.9M |
|
Similar funds
Mason Morfit's Q2 2017 Portfolio in Review
As of Q2 2017, Mason Morfit held 15 positions worth $11.2B, down 6.3% from $11.9B the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Mason Morfit withdrew a net $767M in Q2 2017, reducing 5 holdings. Its largest reduction was Microsoft, cutting an estimated $480M.
By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 28% a quarter earlier, followed by Energy and Technology.
Against the trend, Mason Morfit opened a new position in KKR & Co worth $93M.
- Mason Morfit's largest Q2 2017 buy was KKR & Co: 5,000,000 shares worth $93M.
- Mason Morfit added most to Seagate in Q2 2017, an estimated $187M increase.
- Mason Morfit's biggest Q2 2017 reduction was Microsoft, cutting an estimated $480M.
- Mason Morfit's ten largest holdings make up 91% of its $11.2B portfolio in Q2 2017.
- Mason Morfit opened 1 new position and closed 0 in Q2 2017.
- Mason Morfit's portfolio value fell 6.3% quarter-over-quarter to $11.2B.
Based on ValueAct Holdings's 13F filing for Q2 2017, filed 14 Aug 2017.